First test of new Parkinson's pill in healthy people
Knowledge-focused
Completed
This was an early safety study to see how healthy adults tolerate a new oral drug called ATH-399A. Researchers tested single and multiple doses in 76 healthy volunteers to check for side effects and see how the body absorbs and processes the drug. The goal is to gather informatio…
Phase: PHASE1 • Sponsor: HanAll BioPharma Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC